ACOG Practice Advisory: Zuranolone for the Treatment of Postpartum Depression
ACOG, TA Moore Simas, MC Hoffman, K Roussos-Ross, ES Miller, M Gandhi, A Shields2024
ACOG, TA Moore Simas, MC Hoffman, K Roussos-Ross, ES Miller, M Gandhi, A Shields — 2024
This Practice Advisory serves as an update to Clinical Practice Guideline No. 5, Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum, originally published in 2023. This Practice Advisory is provided to address the August 4, 2023, decision by the U.S. Food and Drug Administration (FDA) to approve zuranolone.
This Practice Advisory serves as an update to Clinical Practice Guideline No. 5, Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum, originally published in 2023. This Practice Advisory is provided to address the August 4, 2023, decision by the U.S. Food and Drug Administration (FDA) to approve zuranolone.